Bo Dong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Bo Dong has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Bo Wu
Department of General Surgery, The Sixth People’s Hospital Affiliated to Shanghai Jiaotong University, Shanghai 200233, China
1 shared publication - Chenchao Ma
Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China
1 shared publication - Hongda Zhu
Department of General Surgery, The Sixth People’s Hospital Affiliated to Shanghai Jiaotong University, Shanghai 200233, China
1 shared publication - Kaixing Ai
Shanghai Pulmonary School, Tongji University School of Medicine, Shanghai, China
1 shared publication - Kate Nong
Department of General Surgery, The Sixth People’s Hospital Affiliated to Shanghai Jiaotong University, Shanghai 200233, China
1 shared publication - Weiwei Wang
School of Energy and Mechanical Engineering, Jiangxi University of Science and Technology, Nanchang 330013, China
1 shared publication
Latest Publications
- Open Access
- 25 June 2014
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 33 (1) , 54
miR-212 promotes pancreatic cancer cell growth and invasion by targeting the hedgehog signaling pathway receptor patched-1
MicroRNAs (miRNAs) are a class of small non-coding RNAs that play important roles in carcinogenesis. In the present study, we investigated the effect of miR-212 on pancreatic ductal adenocarcinoma (PDAC) and its target protein. Quantitative real-time PCR(qRT-PCR) was performed to detect the expression of miR-212 in PDAC tissues and pancreatic cancer cell lines. miR-212 mimic, miR-212 inhibitor and negative control were transfected into pancreatic cancer cells and the effect of miR-212 up-regulation and down-regulation on the proliferation, migration and invasion of cells were investigated. Furthermore, the mRNA and protein levels of Patched-1(PTCH1) were measured. Meanwhile, luciferase assays were performed to validate PTCH1 as miR-212 target in PDAC. miR-212 was up-regulated in PDAC tissues and cells.Using both gain-of function and loss-of function experiments, a pro-oncogenic function of miR-212 was demonstrated in PDAC. Moreover, up-regulated of PTCH1 could attenuate the effect induced by miR-212. These data suggest that miR-212 could facilitate PDAC progression and metastasis through targeting PTCH1, implicating a novel mechanism for the progression of PDAC.
- 25 June 2014
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 33 (1) , 54
Open AccessmiR-212 promotes pancreatic cancer cell growth and invasion by targeting the hedgehog signaling pathway receptor patched-1
MicroRNAs (miRNAs) are a class of small non-coding RNAs that play important roles in carcinogenesis. In the present study, we investigated the effect of miR-212 on pancreatic ductal adenocarcinoma (PDAC) and its target protein. Quantitative real-time PCR(qRT-PCR) was performed to detect the expression of miR-212 in PDAC tissues and pancreatic cancer cell lines. miR-212 mimic, miR-212 inhibitor and negative control were transfected into pancreatic cancer cells and the effect of miR-212 up-regulation and down-regulation on the proliferation, migration and invasion of cells were investigated. Furthermore, the mRNA and protein levels of Patched-1(PTCH1) were measured. Meanwhile, luciferase assays were performed to validate PTCH1 as miR-212 target in PDAC. miR-212 was up-regulated in PDAC tissues and cells.Using both gain-of function and loss-of function experiments, a pro-oncogenic function of miR-212 was demonstrated in PDAC. Moreover, up-regulated of PTCH1 could attenuate the effect induced by miR-212. These data suggest that miR-212 could facilitate PDAC progression and metastasis through targeting PTCH1, implicating a novel mechanism for the progression of PDAC.